Loading asset research
Mineralys Therapeutics Inc. Common Stock
MLYSNasdaq · USD · StocksQuote as of · Exchange session not verified$28.21
-3.72%
Today
MLYS
Loading 1D prices…
Market cap
$2.5B
Volume
1.7M
52w high
$47.6552w low
$22.30Company profile
Mineralys Therapeutics Inc. Common Stock
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Radnor, PA, United States
Employees
76
Fiscal year end
1231
CIK
1933414
Session & valuation
Open$29.65
Previous close$29.30
Day high$29.94
Day low$28.17
30-day avg. volume972K
Outstanding shares88.4M
Diluted EPS-$2.29
Latest annual period
P/E (trailing)-12.32
P/E (forward)-11.28
Price / book4.52
Beta0.68
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| VERAVera Therapeutics Inc. Class A Common Stock | $2.5B | $0.00 | — | -$4.66 | +4.32% | Buy |
| PGENPrecigen Inc. Common Stock | $2.5B | $9.7M | -2587.77% | -$1.37 | +2.54% | Buy |
| SUPNSupernus Pharmaceuticals Inc. Common Stock | $2.4B | $719M | -5.37% | -$0.68 | -0.10% | Buy |
| MRVIMaravai LifeSciences Holdings Inc. Class A Common Stock | $2.4B | $185.7M | -70.42% | -$0.90 | -3.12% | Buy |
| HRMYHarmony Biosciences Holdings Inc. Common Stock | $2.4B | $868.5M | +18.27% | $2.71 | +1.02% | Hold |